Polyzos NP

No ORCID on file · 13 papers in corpus
other 2026
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1880515

OBJECTIVES: This study evaluated the efficacy of individualized follitropin delta dosing in patients with potential low response, defined by anti-Müllerian hormone (AMH) level <9 pmol/L, undergoing ovarian stimulation for assisted reproduct…

observational 2026
Fertility and sterility ·doi:10.1016/j.fertnstert.2026.03.020

OBJECTIVE: To examine intrapatient variability in retrieved oocyte numbers across consecutive in vitro fertilization (IVF) ovarian stimulation (OS) cycles with an identical OS protocol. DESIGN: Cross-continental, multicenter retrospective …

observational 2025
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2025.105107

RESEARCH QUESTION: Are there differences between patients with and without endometriosis in progesterone concentrations the day before artificial-cycle frozen embryo transfer (AC-FET) and in live birth rate (LBR) following subcutaneous prog…

guideline 2024
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-024-01291-x

BACKGROUND: Currently, there is no consensus on the optimal management of women with low prognosis in ART. In this Delphi consensus, a panel of international experts provided real-world clinical perspectives on a series of literature-suppor…

other 2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00605-z

The prolonged lockdown of health services providing high-complexity fertility treatments -as currently recommended by many reproductive medicine entities- is detrimental for society as a whole, and infertility patients in particular. Global…

observational 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2020.03.013

RESEARCH QUESTION: Does the presence of ovarian endometriomas affect ovarian response to ovarian stimulation after adjusting for age and ovarian reserve markers? DESIGN: This retrospective cross-sectional study compared the ovarian respons…

rct 2020
BMJ (Clinical research ed.) ·doi:10.1136/bmj.m2519

OBJECTIVE: To compare the ongoing pregnancy rate between a freeze-all strategy and a fresh transfer strategy in assisted reproductive technology treatment. DESIGN: Multicentre, randomised controlled superiority trial. SETTING: Outpatient …

observational 2019
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01563-1

PURPOSE: To evaluate whether ICSI offers any benefit compared with IVF in different ovarian response categories in case of non-male factor infertility. METHODS: This is a retrospective multicenter analysis using individual patient data, co…

nonrandomized-trial 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00115

Research Question: What is the effect of gonadotropin-releasing hormone (GnRH)-agonist treatment on serum anti-Müllerian hormone (AMH)? Design: This prospective cohort study conducted in a tertiary university hospital comprised patients (n …

observational 2018
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2018.1460346

Since the introduction of gonadotropin-releasing hormone (GnRH) antagonists, an extensive amount of literature investigating the role of the downregulation protocols on pregnancy outcomes has been published. However, these studies were main…

other 2018
Frontiers in endocrinology ·doi:10.3389/fendo.2018.00361

Several infertile patients, who may even represent around 40% of the infertile cohort, may respond "suboptimally" (4-9 oocytes retrieved) following IVF, despite being predicted as normal responders. The aim of our longitudinal study was to …

observational 2012
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-10-42

BACKGROUND: To investigate the obstetrical and perinatal impact of oocyte donation, a cohort of women who conceived after OD was compared with a matched control group of women who became pregnant through in vitro fertilisation with autologo…

review 2011
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-9-90

Postmenopausal endometriosis is a rare clinical condition. The diagnosis and treatment of an endometriotic lesion in postmenopausal women is complicated. First line treatment choice should be surgical, given that there is a potential risk o…